![]() |
![]() |
![]() 新型コロナウィルスSARS-CoV-2に関連するタンパク質と化合物の立体構造 |
![]() |
![]() |
AC | ID | length (amino acids) |
Number of 3D homologues |
short name | full name |
![]() |
AP3A_SARS2 | 275 | 12 | ORF3a; | ORF3a protein; Accessory protein 3a;Protein 3a;Protein U274;Protein X1; |
![]() |
NCAP_SARS2 | 419 | 240 | N; NC ;Protein N ; | Nucleoprotein ; Nucleocapsid protein ; |
![]() |
NS6_SARS2 | 61 | 0 | ORF6; ns6; | ORF6 protein; Accessory protein 6;Non-structural protein 6;Protein X3; |
![]() |
NS7A_SARS2 | 121 | 4 | ORF7a; | ORF7a protein; Accessory protein 7a;Protein U122;Protein X4; |
![]() |
NS7B_SARS2 | 43 | 0 | ORF7b; | ORF7b protein; Accessory protein 7b; |
![]() |
NS8_SARS2 | 121 | 9 | ORF8; ns8; | ORF8 protein; Non-structural protein 8; |
![]() |
ORF3B_SARS2 | 22 | 0 | ORF3b; | Putative ORF3b protein ; |
![]() |
ORF3C_SARS2 | 41 | 0 | ORF3c; ORF3h; | ORF3c protein ; ORF3h protein ; |
![]() |
ORF3D_SARS2 | 57 | 0 | Putative ORF3d protein ; | |
![]() |
ORF9B_SARS2 | 97 | 20 | ORF9b; | ORF9b protein; Accessory protein 9b;ORF-9b;Protein 9b; |
![]() |
ORF9C_SARS2 | 73 | 0 | ORF9c; ORF14; | Putative ORF9c protein ; Uncharacterized protein 14; |
![]() |
R1AB_SARS2 | 7096 | 1500 | pp1ab; | Replicase polyprotein 1ab; ORF1ab polyprotein; |
![]() |
R1A_SARS2 | 4405 | 1500 | pp1a; | Replicase polyprotein 1a; ORF1a polyprotein; |
![]() |
SPIKE_SARS2 | 1273 | 1500 | S glycoprotein ; | Spike glycoprotein ; E2 ;Peplomer protein ; |
![]() |
VEMP_SARS2 | 75 | 11 | E;sM protein ; | Envelope small membrane protein ; |
![]() |
VME1_SARS2 | 222 | 12 | M; | Membrane protein ; E1 glycoprotein ;Matrix glycoprotein ;Membrane glycoprotein ; |
![]() |
AP3A_SARS | 274 | 12 | ORF3a protein; Accessory protein 3a;Protein 3a;Protein U274;Protein X1; | |
![]() |
NCAP_SARS | 422 | 241 | NC ;Protein N ; | Nucleoprotein ; Nucleocapsid protein ; |
![]() |
NS3B_SARS | 154 | 0 | ns3b; | ORF3b protein; Accessory protein 3b;Non-structural protein 3b;Protein X2; |
![]() |
NS6_SARS | 63 | 0 | ORF6; ns6; | ORF6 protein; Accessory protein 6;Non-structural protein 6;Protein X3; |
![]() |
NS7A_SARS | 122 | 4 | ORF7a protein; Accessory protein 7a;Protein U122;Protein X4; | |
![]() |
NS7B_SARS | 44 | 0 | ns7b; | Protein non-structural 7b; Accessory protein 7b; |
![]() |
NS8A_SARS | 39 | 0 | ns8a; | ORF8a protein; Accessory protein 8a;Protein non-structural 8a; |
![]() |
NS8B_SARS | 84 | 0 | ns8b; | ORF8b protein; Accessory protein 8b;Non-structural protein 8b; |
![]() |
ORF9B_SARS | 98 | 20 | ORF9b protein; Accessory protein 9b;ORF-9b;Protein 9b; | |
![]() |
R1AB_SARS | 7073 | 1500 | pp1ab; | Replicase polyprotein 1ab; ORF1ab polyprotein; |
![]() |
R1A_SARS | 4382 | 1500 | pp1a; | Replicase polyprotein 1a; ORF1a polyprotein; |
![]() |
SPIKE_SARS | 1255 | 1500 | S glycoprotein ; | Spike glycoprotein ; E2 ;Peplomer protein ; |
![]() |
VEMP_SARS | 76 | 11 | E protein ;sM protein ; | Envelope small membrane protein ; |
![]() |
VME1_SARS | 221 | 12 | M protein ; | Membrane protein ; E1 glycoprotein ;Matrix glycoprotein ;Membrane glycoprotein ; |
![]() |
Y14_SARS | 70 | 0 | Uncharacterized protein 14; | |
![]() |
ACE2_HUMAN | 805 | 509 | ACEH ;ACE-related carboxypeptidase; | Angiotensin-converting enzyme 2; Angiotensin-converting enzyme homolog ;Angiotensin-converting enzyme-related carboxypeptidase ;Metalloprotease MPROT15 {ECO:0000303|Ref.6}; |
![]() |
AGTR1_HUMAN | 359 | 825 | AT1 receptor ; | Type-1 angiotensin II receptor ; AT1AR ;AT1BR;Angiotensin II type-1 receptor ; |
![]() |
ANO6_HUMAN | 910 | 103 | SCAN channel; | Anoctamin-6 ; Small-conductance calcium-activated nonselective cation channel;Transmembrane protein 16F; |
![]() |
APOE_HUMAN | 317 | 39 | Apo-E; | Apolipoprotein E ; |
![]() |
ARL8B_HUMAN | 186 | 1473 | ADP-ribosylation factor-like protein 8B ; ADP-ribosylation factor-like protein 10C;Novel small G protein indispensable for equal chromosome segregation 1; | |
![]() |
ASM_HUMAN | 631 | 32 | aSMase; | Sphingomyelin phosphodiesterase ; Acid sphingomyelinase {ECO:0000303|PubMed:25339683, ECO:0000303|PubMed:27349982, ECO:0000303|PubMed:33163980}; |
![]() |
BASI_HUMAN | 385 | 48 | EMMPRIN;HAb18G ;TCSF; | Basigin ; 5F7;Collagenase stimulatory factor;Extracellular matrix metalloproteinase inducer;Hepatoma-associated antigen ;Leukocyte activation antigen M6;OK blood group antigen;Tumor cell-derived collagenase stimulatory factor; |
![]() |
BMAL1_HUMAN | 626 | 160 | bHLHe5; | Basic helix-loop-helix ARNT-like protein 1 ; Aryl hydrocarbon receptor nuclear translocator-like protein 1;Basic-helix-loop-helix-PAS protein MOP3;Brain and muscle ARNT-like 1;Class E basic helix-loop-helix protein 5;Member of PAS protein 3;PAS domain-containing protein 3;bHLH-PAS protein JAP3; |
![]() |
BST2_HUMAN | 180 | 47 | BST-2; | Bone marrow stromal antigen 2; HM1.24 antigen;Tetherin; |
![]() |
C2TA_HUMAN | 1130 | 68 | CIITA ; | MHC class II transactivator ; |
![]() |
CATL1_HUMAN | 333 | 810 | MEP; | Procathepsin L ; Cathepsin L1 ;Major excreted protein; |
![]() |
CH25H_HUMAN | 272 | 0 | h25OH; | Cholesterol 25-hydroxylase ; Cholesterol 25-monooxygenase; |
![]() |
DDX1_HUMAN | 740 | 826 | DBP-RB; | ATP-dependent RNA helicase DDX1; DEAD box protein 1;DEAD box protein retinoblastoma; |
![]() |
RIGI_HUMAN | 925 | 205 | RLR-1;RIG-1;RIG-I; | Antiviral innate immune response receptor RIG-I ; ATP-dependent RNA helicase DDX58 ;DEAD box protein 58;RIG-I-like receptor 1;RNA sensor RIG-I ;Retinoic acid-inducible gene 1 protein;Retinoic acid-inducible gene I protein; |
![]() |
DHX58_HUMAN | 678 | 217 | RLR-3;RLR; | ATP-dependent RNA helicase DHX58 ; ATP-dependent helicase LGP2 ;Protein D11Lgp2 homolog;RIG-I-like receptor 3;RIG-I-like receptor LGP2; |
![]() |
EF1A1_HUMAN | 462 | 449 | EF-1-alpha-1; EF-Tu;eEF1A-1; | Elongation factor 1-alpha 1; Elongation factor Tu;Eukaryotic elongation factor 1 A-1;Leukocyte receptor cluster member 7; |
![]() |
FAS_HUMAN | 2511 | 848 | Fatty acid synthase; Type I fatty acid synthase; | |
![]() |
FURIN_HUMAN | 794 | 252 | PACE; | Furin ; Dibasic-processing enzyme;Paired basic amino acid residue-cleaving enzyme; |
![]() |
FYV1_HUMAN | 2098 | 451 | Phosphatidylinositol 3-phosphate 5-kinase; PIPkin-III;Type III PIP kinase; | 1-phosphatidylinositol 3-phosphate 5-kinase ; FYVE finger-containing phosphoinositide kinase;PIKfyve;Phosphatidylinositol 3-phosphate 5-kinase type III;Serine-protein kinase PIKFYVE; |
![]() |
HG2A_HUMAN | 296 | 35 | Ii; | HLA class II histocompatibility antigen gamma chain ; HLA-DR antigens-associated invariant chain;Ia antigen-associated invariant chain; |
![]() |
HIF1A_HUMAN | 826 | 162 | HIF-1-alpha ;HIF1-alpha ; bHLHe78; | Hypoxia-inducible factor 1-alpha ; ARNT-interacting protein;Basic-helix-loop-helix-PAS protein MOP1 ;Class E basic helix-loop-helix protein 78;Member of PAS protein 1 ;PAS domain-containing protein 8; |
![]() |
HLAA_HUMAN | 365 | 1500 | HLA-A; | HLA class I histocompatibility antigen, A alpha chain; Human leukocyte antigen A; |
![]() |
HLAB_HUMAN | 362 | 1500 | HLA-B; | HLA class I histocompatibility antigen, B alpha chain; Human leukocyte antigen B; |
![]() |
HLAE_HUMAN | 358 | 1500 | HLA class I histocompatibility antigen, alpha chain E; MHC class I antigen E; | |
![]() |
HMGB1_HUMAN | 215 | 93 | HMG-1; | High mobility group protein B1; High mobility group protein 1; |
![]() |
I17RA_HUMAN | 866 | 28 | IL-17 receptor A;IL-17RA; | Interleukin-17 receptor A ; CDw217; |
![]() |
I17RC_HUMAN | 791 | 6 | IL-17 receptor C;IL-17RC; IL17Rhom;IL-17RL; | Interleukin-17 receptor C; Interleukin-17 receptor homolog;Interleukin-17 receptor-like protein;ZcytoR14; |
![]() |
IFIH1_HUMAN | 1025 | 297 | CADM-140 autoantigen;Helicard;MDA-5;RLR-2; | Interferon-induced helicase C domain-containing protein 1 ; Clinically amyopathic dermatomyositis autoantigen 140 kDa;Helicase with 2 CARD domains;Interferon-induced with helicase C domain protein 1;Melanoma differentiation-associated protein 5;Murabutide down-regulated protein;RIG-I-like receptor 2;RNA helicase-DEAD box protein 116; |
![]() |
IFM1_HUMAN | 125 | 0 | DSPA2a; | Interferon-induced transmembrane protein 1 ; Dispanin subfamily A member 2a;Interferon-induced protein 17;Interferon-inducible protein 9-27;Leu-13 antigen; |
![]() |
IFM2_HUMAN | 132 | 0 | DSPA2c; | Interferon-induced transmembrane protein 2 ; Dispanin subfamily A member 2c;Interferon-inducible protein 1-8D; |
![]() |
IFM3_HUMAN | 133 | 0 | DSPA2b; | Interferon-induced transmembrane protein 3 ; Dispanin subfamily A member 2b;Interferon-inducible protein 1-8U; |
![]() |
IL17F_HUMAN | 163 | 87 | IL-17F; | Interleukin-17F; Cytokine ML-1; |
![]() |
IL17_HUMAN | 155 | 81 | IL-17;IL-17A; CTLA-8; | Interleukin-17A; Cytotoxic T-lymphocyte-associated antigen 8; |
![]() |
IL6RA_HUMAN | 468 | 73 | IL-6 receptor subunit alpha;IL-6R subunit alpha;IL-6R-alpha;IL-6RA; gp80; | Interleukin-6 receptor subunit alpha ; IL-6R 1;Membrane glycoprotein 80; |
![]() |
IL6RB_HUMAN | 918 | 130 | IL-6 receptor subunit beta;IL-6R subunit beta;IL-6R-beta;IL-6RB; gp130 ; | Interleukin-6 receptor subunit beta ; CDw130;Interleukin-6 signal transducer;Membrane glycoprotein 130;Oncostatin-M receptor subunit alpha; |
![]() |
IL6_HUMAN | 212 | 20 | IL-6; BSF-2;CDF;IFN-beta-2; | Interleukin-6 ; B-cell stimulatory factor 2;CTL differentiation factor;Hybridoma growth factor;Interferon beta-2; |
![]() |
IMA1_HUMAN | 529 | 460 | Importin subunit alpha-1 ; Karyopherin subunit alpha-2;RAG cohort protein 1;SRP1-alpha; | |
![]() |
INAR1_HUMAN | 557 | 46 | IFN-R-1;IFN-alpha/beta receptor 1; CRF2-1; | Interferon alpha/beta receptor 1; Cytokine receptor class-II member 1;Cytokine receptor family 2 member 1;Type I interferon receptor 1; |
![]() |
INAR2_HUMAN | 515 | 12 | IFN-R-2;IFN-alpha binding protein;IFN-alpha/beta receptor 2; | Interferon alpha/beta receptor 2; Interferon alpha binding protein;Type I interferon receptor 2; |
![]() |
IRF3_HUMAN | 427 | 77 | IRF-3 ; | Interferon regulatory factor 3 {ECO:0000303|PubMed:9566918, ECO:0000303|PubMed:9803267}; |
![]() |
IRF5_HUMAN | 498 | 79 | IRF-5 ; | Interferon regulatory factor 5 ; |
![]() |
IRF7_HUMAN | 503 | 77 | IRF-7; | Interferon regulatory factor 7; |
![]() |
ISG15_HUMAN | 165 | 1453 | IP17;hUCRP; | Ubiquitin-like protein ISG15; Interferon-induced 15 kDa protein;Interferon-induced 17 kDa protein;Ubiquitin cross-reactive protein; |
![]() |
ITAL_HUMAN | 1170 | 387 | LFA-1A; | Integrin alpha-L ; CD11 antigen-like family member A;Leukocyte adhesion glycoprotein LFA-1 alpha chain;Leukocyte function-associated molecule 1 alpha chain; |
![]() |
KLRD1_HUMAN | 179 | 583 | Natural killer cells antigen CD94; KP43;Killer cell lectin-like receptor subfamily D member 1;NK cell receptor; | |
![]() |
LY6E_HUMAN | 131 | 0 | Ly-6E; RIG-E;SCA-2;TSA-1; | Lymphocyte antigen 6E ; Retinoic acid-induced gene E protein;Stem cell antigen 2;Thymic shared antigen 1; |
![]() |
MAVS_HUMAN | 540 | 46 | MAVS ; Cardif ;IPS-1;VISA; | Mitochondrial antiviral-signaling protein ; CARD adapter inducing interferon beta ;Interferon beta promoter stimulator protein 1;Putative NF-kappa-B-activating protein 031N;Virus-induced-signaling adapter; |
![]() |
MTA70_HUMAN | 580 | 139 | hMETTL3 ;MT-A70; | N6-adenosine-methyltransferase catalytic subunit ; Methyltransferase-like protein 3 ;N6-adenosine-methyltransferase 70 kDa subunit; |
![]() |
MYD88_HUMAN | 296 | 61 | Myeloid differentiation primary response protein MyD88 ; | |
![]() |
NEMO_HUMAN | 419 | 46 | NEMO ; IKKAP1;I-kappa-B kinase subunit gamma;IKK-gamma;IKKG;IkB kinase subunit gamma; | NF-kappa-B essential modulator ; FIP-3;IkB kinase-associated protein 1;Inhibitor of nuclear factor kappa-B kinase subunit gamma;NF-kappa-B essential modifier; |
![]() |
NEU2_HUMAN | 164 | 29 | Vasopressin-neurophysin 2-copeptin; AVP-NPII; | |
![]() |
NF2L2_HUMAN | 605 | 12 | NF-E2-related factor 2 ;NFE2-related factor 2 ;Nrf-2 ; | Nuclear factor erythroid 2-related factor 2 ; HEBP1;Nuclear factor, erythroid derived 2, like 2 {ECO:0000303|PubMed:33009401, ECO:0000303|PubMed:7937919}; |
![]() |
NHRF1_HUMAN | 358 | 318 | NHERF-1; EBP50; | Na(+)/H(+) exchange regulatory cofactor NHE-RF1 ; Ezrin-radixin-moesin-binding phosphoprotein 50;Regulatory cofactor of Na(+)/H(+) exchanger;Sodium-hydrogen exchanger regulatory factor 1;Solute carrier family 9 isoform A3 regulatory factor 1; |
![]() |
NKG2A_HUMAN | 233 | 409 | NKG2-A/NKG2-B type II integral membrane protein; CD159 antigen-like family member A;NK cell receptor A;NKG2-A/B-activating NK receptor; | |
![]() |
NLRP1_HUMAN | 1473 | 247 | NACHT, LRR and PYD domains-containing protein 1 ; Caspase recruitment domain-containing protein 7;Death effector filament-forming ced-4-like apoptosis protein ;Nucleotide-binding domain and caspase recruitment domain; | |
![]() |
NLRP3_HUMAN | 1036 | 174 | CLR1.1 ; | NACHT, LRR and PYD domains-containing protein 3 ; Angiotensin/vasopressin receptor AII/AVP-like;Caterpiller protein 1.1 ;Cold-induced autoinflammatory syndrome 1 protein ;Cryopyrin ;PYRIN-containing APAF1-like protein 1 ; |
![]() |
NRP1_HUMAN | 923 | 224 | Neuropilin-1 ; Vascular endothelial cell growth factor 165 receptor; | |
![]() |
NUP98_HUMAN | 1817 | 207 | Nuclear pore complex protein Nup98-Nup96 ; | |
![]() |
OAS1_HUMAN | 400 | 13 | (2-5')oligo(A) synthase 1;2-5A synthase 1; | 2'-5'-oligoadenylate synthase 1; E18/E16;p46/p42 OAS; |
![]() |
PAIP1_HUMAN | 479 | 8 | PABP-interacting protein 1;PAIP-1;Poly(A)-binding protein-interacting protein 1; | Polyadenylate-binding protein-interacting protein 1 ; |
![]() |
PALS1_HUMAN | 675 | 202 | Protein PALS1 ; MAGUK p55 subfamily member 5;Membrane protein, palmitoylated 5 ;Protein associated with Lin-7 1 {ECO:0000303|PubMed:12527193, ECO:0000312|HGNC:HGNC:18669}; | |
![]() |
PHB1_HUMAN | 272 | 1 | Prohibitin 1 ; | |
![]() |
PHB2_HUMAN | 299 | 1 | Prohibitin-2; B-cell receptor-associated protein BAP37;D-prohibitin;Repressor of estrogen receptor activity; | |
![]() |
PK3C3_HUMAN | 887 | 522 | PI3-kinase type 3;PI3K type 3;PtdIns-3-kinase type 3; | Phosphatidylinositol 3-kinase catalytic subunit type 3; Phosphatidylinositol 3-kinase p100 subunit;Phosphoinositide-3-kinase class 3;hVps34; |
![]() |
PPIA_HUMAN | 165 | 593 | PPIase A; | Peptidyl-prolyl cis-trans isomerase A; Cyclophilin A;Cyclosporin A-binding protein;Rotamase A; |
![]() |
RAB7A_HUMAN | 207 | 1500 | Ras-related protein Rab-7a ; | |
![]() |
S10A8_HUMAN | 93 | 428 | CFAG;MRP-8;p8; | Protein S100-A8 ; Calgranulin-A;Calprotectin L1L subunit;Cystic fibrosis antigen;Leukocyte L1 complex light chain;Migration inhibitory factor-related protein 8;S100 calcium-binding protein A8;Urinary stone protein band A; |
![]() |
SGTA_HUMAN | 313 | 289 | UBP; | Small glutamine-rich tetratricopeptide repeat-containing protein alpha; Alpha-SGT;Vpu-binding protein; |
![]() |
SMAD3_HUMAN | 425 | 91 | MAD homolog 3;Mad3;Mothers against DPP homolog 3;hMAD-3; SMAD 3;Smad3;hSMAD3; | Mothers against decapentaplegic homolog 3; JV15-2;SMAD family member 3; |
![]() |
SNP29_HUMAN | 258 | 14 | SNAP-29 ; | Synaptosomal-associated protein 29 ; Soluble 29 kDa NSF attachment protein ;Vesicle-membrane fusion protein SNAP-29; |
![]() |
STX17_HUMAN | 302 | 9 | Syntaxin-17 ; | |
![]() |
TBK1_HUMAN | 729 | 1500 | Serine/threonine-protein kinase TBK1 ; NF-kappa-B-activating kinase ;T2K;TANK-binding kinase 1 ; | |
![]() |
TCAM1_HUMAN | 712 | 11 | TICAM-1; MyD88-3;TIR domain-containing adapter protein inducing IFN-beta; | TIR domain-containing adapter molecule 1; Proline-rich, vinculin and TIR domain-containing protein B;Putative NF-kappa-B-activating protein 502H;Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta; |
![]() |
TLR3_HUMAN | 904 | 792 | Toll-like receptor 3 ; | |
![]() |
TLR7_HUMAN | 1049 | 703 | Toll-like receptor 7 ; | |
![]() |
TLR8_HUMAN | 1041 | 594 | Toll-like receptor 8 ; | |
![]() |
TM41B_HUMAN | 291 | 0 | Transmembrane protein 41B ; Protein stasimon ; | |
![]() |
TMPS2_HUMAN | 492 | 1500 | Transmembrane protease serine 2 ; Serine protease 10 ; | |
![]() |
TMPS4_HUMAN | 437 | 1500 | CAPH2;MT-SP2; | Transmembrane protease serine 4 ; Channel-activating protease 2;Membrane-type serine protease 2; |
![]() |
TOM70_HUMAN | 608 | 168 | Mitochondrial import receptor subunit TOM70 ; Mitochondrial precursor proteins import receptor;Translocase of outer membrane 70 kDa subunit;Translocase of outer mitochondrial membrane protein 70 ; | |
![]() |
TPC2_HUMAN | 752 | 147 | Two pore channel protein 2; Two pore calcium channel protein 2; | |
![]() |
TYK2_HUMAN | 1187 | 1500 | Non-receptor tyrosine-protein kinase TYK2; | |
![]() |
V1BR_HUMAN | 424 | 534 | V1bR; | Vasopressin V1b receptor ; AVPR V1b;AVPR V3;Antidiuretic hormone receptor 1b;Vasopressin V3 receptor; |
![]() |
VAMP8_HUMAN | 100 | 50 | VAMP-8 ; EDB ; | Vesicle-associated membrane protein 8 ; Endobrevin ; |
![]() |
VPS39_HUMAN | 886 | 4 | hVam6p; | Vam6/Vps39-like protein ; TRAP1-like protein; |
![]() |
VPS41_HUMAN | 854 | 0 | Vacuolar protein sorting-associated protein 41 homolog; S53; | |
![]() |
ZDH20_HUMAN | 365 | 10 | DHHC20 ; | Palmitoyltransferase ZDHHC20 ; Acyltransferase ZDHHC20 ;DHHC domain-containing cysteine-rich protein 20 ;Zinc finger DHHC domain-containing protein 20 ; |
![]() |
ZDHC8_HUMAN | 765 | 10 | DHHC-8 ; | Palmitoyltransferase ZDHHC8 ; Zinc finger DHHC domain-containing protein 8 ;Zinc finger protein 378; |
![]() |
ZDHC9_HUMAN | 364 | 10 | DHHC-9;DHHC9; | Palmitoyltransferase ZDHHC9; Zinc finger DHHC domain-containing protein 9;Zinc finger protein 379;Zinc finger protein 380; |
protein_id | length (amino acids) |
Number of 3D homologues |
product | gene | note |
![]() |
7096 | 1500 | 2'-O-ribose methyltransferase | orf1ab | pp1ab; translated by -1 ribosomal frameshift |
![]() |
180 | 28 | leader protein | nsp1; produced by both pp1a and pp1ab | |
![]() |
638 | 8 | nsp2 | produced by both pp1a and pp1ab | |
![]() |
1945 | 1222 | nsp3 | former nsp1; conserved domains are: N-terminal | |
![]() |
500 | 9 | nsp4 | nsp4B_TM; contains transmembrane domain 2 (TM2); | |
![]() |
306 | 1500 | 3C-like proteinase | nsp5A_3CLpro and nsp5B_3CLpro; main proteinase | |
![]() |
290 | 0 | nsp6 | nsp6_TM; putative transmembrane domain; produced by | |
![]() |
83 | 87 | nsp7 | produced by both pp1a and pp1ab | |
![]() |
198 | 133 | nsp8 | produced by both pp1a and pp1ab | |
![]() |
113 | 60 | nsp9 | ssRNA-binding protein; produced by both pp1a and | |
![]() |
139 | 143 | nsp10 | nsp10_CysHis; formerly known as growth-factor-like | |
![]() |
932 | 60 | RNA-dependent RNA polymerase | nsp12; NiRAN and RdRp; produced by pp1ab only | |
![]() |
601 | 164 | helicase | nsp13_ZBD, nsp13_TB, and nsp_HEL1core; zinc-binding | |
![]() |
527 | 91 | 3'-to-5' exonuclease | nsp14A2_ExoN and nsp14B_NMT; produced by pp1ab | |
![]() |
346 | 163 | endoRNAse | nsp15-A1 and nsp15B-NendoU; produced by pp1ab only | |
![]() |
298 | 62 | 2'-O-ribose methyltransferase | nsp16_OMT; 2'-o-MT; produced by pp1ab only | |
![]() |
4405 | 1500 | nsp11 | orf1ab | pp1a |
![]() |
13 | 0 | nsp11 | produced by pp1a only | |
![]() |
1273 | 1500 | surface glycoprotein | S | structural protein; spike protein |
![]() |
275 | 12 | ORF3a protein | ORF3a | |
![]() |
75 | 11 | envelope protein | E | ORF4; structural protein; E protein |
![]() |
222 | 12 | membrane glycoprotein | M | ORF5; structural protein |
![]() |
61 | 0 | ORF6 protein | ORF6 | |
![]() |
121 | 4 | ORF7a protein | ORF7a | |
![]() |
43 | 0 | ORF7b | ORF7b | |
![]() |
121 | 9 | ORF8 protein | ORF8 | |
![]() |
419 | 240 | nucleocapsid phosphoprotein | N | ORF9; structural protein |
![]() |
38 | 0 | ORF10 protein | ORF10 |
KEGG_ID | 構造式 | 一般名 | Number of identical compounds |
Number of similar compounds (tanimoto=0.5) |
商品名 | 効能 |
![]() |
D01703 シクレソニド (JAN); Ciclesonide (JAN/USAN/INN) | 0 | 9 | オルベスコ (帝人ファーマ) 00059259 | 喘息治療薬, 抗炎症薬, グルココルチコイド受容体作動薬 | |
![]() |
D01425 ロピナビル (JAN); Lopinavir (JAN/USP/INN) | 1 | 39 | 抗ウイルス薬, HIVプロテアーゼ阻害薬 | ||
![]() |
D00427 リトナビル (JAN); Ritonavir (JAN/USP/INN) | 1 | 31 | ノービア (アッヴィ) 00059362 | 抗ウイルス薬, HIVプロテアーゼ阻害薬 | |
![]() |
D09537 ファビピラビル (JAN); Favipiravir (JAN/USAN/INN) | 0 | 65 | アビガン (富士フイルム富山化学) 00066852 | 抗ウイルス薬, RNAレプリカーゼ阻害薬 | |
![]() |
D09537_1 ファビピラビル・リボフラノシルリン酸体; Favipiravir-RMP; ファビピラビル活性体; | 1 | 150 | 抗ウイルス薬, RNAレプリカーゼ阻害薬 | ||
![]() |
D09537_2 ファビピラビル・リボフラノシル二リン酸体; Favipiravir-RDP; ファビピラビル活性体; | 0 | 141 | 抗ウイルス薬, RNAレプリカーゼ阻害薬 | ||
![]() |
D09537_3 ファビピラビル・リボフラノシル三リン酸体; Favipiravir-RTP; ファビピラビル活性体; | 1 | 150 | 抗ウイルス薬, RNAレプリカーゼ阻害薬 | ||
![]() |
D11472 レムデシビル (JAN); Remdesivir (JAN/USAN) | 0 | 4 | ベクルリー (ギリアド・サイエンシズ) 00069661 | 抗ウイルス薬, RNAポリメラーゼ阻害薬 | |
![]() |
D11472_1 レムデシビルリン酸体; Remdesivir-monophosphate (USAN | 1 | 149 | 抗ウイルス薬 | ||
![]() |
D11472_2 レムデシビル二リン酸体; Remdesivir-diphosphate (USAN | 0 | 133 | 抗ウイルス薬 | ||
![]() |
D11472_3 レムデシビル三リン酸体; Remdesivir-triphosphate (USAN | 1 | 149 | 抗ウイルス薬 | ||
![]() |
D02366 クロロキン; Chloroquine (USP/INN) | 2 | 31 | 抗マラリア薬, 抗アメーバ薬 | ||
![]() |
D08050 ヒドロキシクロロキン; Hydroxychloroquine (INN) | 0 | 23 | 抗マラリア薬 | ||
![]() |
D01670 ナファモスタットメシル酸塩 (JP18); Nafamostat mesylate (USAN); Nafamostat mesilate (JP18) | 1 | 31 | フサン (日医工) 00048710 | 抗凝固薬, 抗線溶薬, セリンプロテアーゼ阻害薬 | |
![]() |
D00429 サキナビル (JAN); Saquinavir (JAN/USP/INN) | 1 | 10 | 抗ウイルス薬, HIVプロテアーゼ阻害薬 | ||
![]() |
D01035 セファランチン (JAN); タマサキツヅラフジ抽出アルカロイド; Cepharanthine (JAN) | 0 | 0 | セファランチン (メディサ新薬) 00050591 セファランチン (メディサ新薬) 00060363 | 抗アレルギー薬, 血行促進薬 | |
![]() |
D00804 イベルメクチン (JAN); Ivermectin (JAN/USP/INN) | 0 | 1 | ストロメクトール (MSD) 00049234 | 抗寄生虫薬 | |
![]() |
D00292 デキサメタゾン (JP18); Dexamethasone (JP18/USP/INN) | 1 | 110 | アフタゾロン (あゆみ製薬) 00054356 デカドロン (日医工) 00054772 デカドロン (日医工) 00062800 レナデックス (ブリストル・マイヤーズスクイブ) 00069302 | 抗炎症薬, 鎮痒薬, グルココルチコイド受容体作動薬 | |
![]() |
D07486 アジスロマイシン; Azithromycin (INN) | 1 | 25 | 抗生物質, タンパク質合成阻害薬 | ||
![]() |
D08897 ダパグリフロジン; Dapagliflozin (USAN/INN) | 0 | 35 | 糖尿病治療薬, SGLT-2阻害薬 | ||
![]() |
D00570 コルヒチン (JP18); Colchicine (JP18/USP) | 1 | 10 | コルヒチン (高田製薬) 00058355 | 痛風治療薬, 白血球(好中球)遊走阻害薬, 微小管重合阻害薬 | |
![]() |
D07606 カモスタット; Camostat (INN) | 0 | 13 | 抗炎症薬, セリンプロテアーゼ阻害薬 | ||
![]() |
D10308 バリシチニブ (JAN); Baricitinib (JAN/USAN/INN) | 1 | 9 | オルミエント (日本イーライリリー) 00066989 | 抗炎症薬, 抗リウマチ薬, 免疫抑制薬, ヤヌスキナーゼ(JAK)阻害薬 | |
![]() |
D11943 モルヌピラビル (JAN); Molnupiravir (JAN/USAN) | 0 | 112 | ラゲブリオ (MSD) 00070173 | 抗ウイルス薬 | |
![]() |
D12244 ニルマトレルビル (JAN); PF-07321332; Nirmatrelvir (JAN/USAN); PF-07321332 | 3 | 47 | 抗ウイルス薬 | ||
![]() |
D03506 塩酸シナンセリン; Cinanserin hydrochloride (USAN) | 0 | 29 | 抗ウイルス薬 |
HOMCOSは、現在、文部科学省の創薬等支援技術基盤プラットフォーム事業の支援を受け、大阪大学 蛋白研 プロテインデータバンク研究室により開発・維持されています。
参考文献